Pricing Log in Create free account

InMed Pharmaceuticals Inc. (INM) vs cbdMD, Inc. (YCBD)

InMed Pharmaceuticals Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $4.4M — 1.7× the size. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −6.73%. InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −14.7%) and the higher return on invested capital (0.00% vs −29.8%). Across the 15 metrics below, cbdMD, Inc. leads on 8 and InMed Pharmaceuticals Inc. on 7.

Valuation

Metric INM YCBD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 15.78 0.19 2.08
P/B n/m 0.49 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 15.54 0.21 2.87
Earnings yield (23.08%) (80.50%) (15.94%)
Free cash flow yield (11.11%) (61.46%) 0.00%

Profitability

Metric INM YCBD Drug Manufacturers Specialty & Generic median
Gross margin 33.62% 57.68% 53.51%
Operating margin 0.00% (13.87%) 0.00%
Net margin 0.00% (14.71%) (2.45%)
Free cash flow margin 0.00% (11.51%) 0.00%
Return on equity (261.69%) (43.01%) (0.80%)
Return on assets (185.40%) (26.73%) (1.67%)
Return on invested capital 0.00% (29.78%) 0.00%

Growth

Metric INM YCBD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (6.73%) 10.01% 5.22%
EPS growth (last fiscal year) 62.68% 92.39% 42.91%
Revenue growth, 5-year CAGR — (14.45%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INM YCBD Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 0.50 2.50 2.41
Net debt to EBITDA 0.20 6.17 1.01

Dividend

Metric INM YCBD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric INM YCBD Drug Manufacturers Specialty & Generic median
Market cap 7.26m 4.35m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack